title: Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
authors.forename: G
authors.initials: G
authors.lastname: Licata
authors.forename: A
authors.initials: A
authors.lastname: Pinto
authors.forename: A
authors.initials: A
authors.lastname: Tuttolomondo
authors.forename: A
authors.initials: A
authors.lastname: Banco
authors.forename: F
authors.initials: F
authors.lastname: Ciccia
authors.forename: A
authors.initials: A
authors.lastname: Ferrante
authors.forename: G
authors.initials: G
authors.lastname: Triolo
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D020293:Vasculitis, Central Nervous System / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab